Cephalon, Inc. Drug Needs Stronger Child Warning-US Panel

GAITHERSBURG, Md., Nov 28 (Reuters) - U.S. health advisers called for stronger warning labels on Wednesday on Cephalon (CEPH.O: Quote, Profile, Research) biggest drug, Provigil, noting the treatment for sleep disorder narcolepsy is not recommended in children.
MORE ON THIS TOPIC